US2007026433A1PendingUtilityA1
Epitope testing using soluble HLA
Individually held — no corporate assignee on recordPriority: Mar 9, 2001Filed: Jun 12, 2006Published: Feb 1, 2007
Est. expiryMar 9, 2021(expired)· nominal 20-yr term from priority
G01N 2333/70539G01N 33/6878G01N 33/56977
35
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates generally to a methodology for assaying the binding of a peptide to an individual, specific, soluble HLA molecule using fluorescence polarization. The peptides utilized in the method may be identified by indirect methods utilizing T lymphocytes, or by a direct method of epitope discovery described herein.
Claims
exact text as granted — not AI-modified1 . A method of assaying a peptide for binding to an individual class I molecule, the method comprising the steps of:
providing a first peptide, wherein the first peptide is known to bind to a specific class I molecule; labeling the first peptide; providing individual soluble, specific class I molecules; mixing the labeled first peptide with the individual soluble, specific class I molecules to provide individual soluble, specific class I molecule-labeled first peptide complexes; isolating the individual soluble, specific class I molecule-labeled first peptide complexes; providing a second peptide, wherein the second peptide is a peptide of interest; mixing the second peptide with the individual soluble, specific class I molecule-labeled first peptide complexes; and identifying individual soluble, specific class I molecule-second peptide complexes, wherein the second peptide has displaced the labeled first peptide and the individual soluble, specific class I molecule has the second peptide loaded therein.
2 . The method of claim 1 wherein, in the step of labeling the first peptide, the first peptide is labeled with a radiolabel or a fluorescent label.
3 . The method of claim 2 wherein, in the step of identifying individual soluble, specific class I molecule-second peptide complexes, the first peptide is labeled with a fluorescent label, and the individual soluble, specific class I molecule-second peptide complexes are identified by fluorescence polarization.
4 . The method of claim 1 wherein, in the method of providing individual soluble, specific class I molecules, the individual soluble, specific class I molecules are produced by the method comprising the steps of:
obtaining genomic DNA or cDNA encoding at least one class I molecule; identifying an allele encoding an individual class I molecule in the genomic DNA or cDNA; PCR amplifying the allele encoding the individual class I molecule in a locus specific manner such that a PCR product produced therefrom encodes a truncated, soluble form of the individual class I molecule; cloning the PCR product into an expression vector, thereby forming a construct that encodes the individual soluble, specific class I molecule; transfecting the construct into a cell line to provide a cell line containing a construct that encodes an individual soluble, specific class I molecule, the cell line being able to naturally process proteins into peptide ligands capable of being loaded into antigen binding grooves of class I molecules; culturing the cell line under conditions which allow for expression of the individual soluble, specific class I molecules from the construct, such conditions also allowing for endogenous loading of a peptide ligand into the antigen binding groove of each individual soluble, specific class I molecule prior to secretion of the individual soluble, specific class I molecules from the cell; and isolating the secreted individual soluble, specific class I molecules.
5 . The method of claim 4 wherein the construct further encodes a tag which is attached to the individual soluble, specific class I molecule and aids in isolating the individual soluble, specific class I molecule.
6 . The method of claim 5 wherein the tag is selected from the group consisting of a HIS tail and a FLAG tail.Join the waitlist — get patent alerts
Track US2007026433A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.